Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.90 USD
Change Today -0.02 / -1.04%
Volume 690.7K
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 12:20 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stuart D. Sedlack M.B.A.

Senior Vice President of Corporate Development, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

49--

Background*

Mr. Stuart D. Sedlack, MBA serves as Senior Vice President of Business Development at Velocity Pharmaceutical Development, LLC. Mr. Sedlack served as Senior Vice President of Corporate Development at Amarin Corporation plc (also known as Amarin Pharmaceuticals). Mr. Sedlack joins VPD with a significant record of achievement sourcing, negotiating and managing partnerships in the life science industry. He was responsible for strategic and operational initiatives including ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

2004-N/A
Former Director

Education*

Bachelor's Degree
University of Richmond
BA
University of Richmond
BS
University of Richmond
MBA
Babson College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.90 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
$301.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$643.4K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.